Delaware Company to Pay More Than $3.34 Million to Resolve False Claims Act Allegations Related to Paycheck Protection Program Loan
Novum Pharmaceutical Research Services of Delaware, Inc. (“Novum”), a Delaware corporation with its principal place of business in Pittsburgh, Pennsylvania, has agreed to pay $3,345,000 to resolve allegations that it improperly obtained a Paycheck Protection Program (“PPP”) loan from the U.S. Small Business Administration (“SBA”) for which it was not eligible.
Contenu original affiche; la traduction localisee n'est pas encore disponible.
Ce qui s'est passé
Novum Pharmaceutical Research Services of Delaware, Inc. (“Novum”), a Delaware corporation with its principal place of business in Pittsburgh, Pennsylvania, has agreed to pay $3,345,000 to resolve allegations that it improperly obtained a Paycheck Protection Program (“PPP”) loan from the U.S. Small Business Administration (“SBA”) for which it was not eligible.
Pourquoi c'est important
The development may change operating conditions or market expectations around Regulation. Further confirmation and measurable outcomes matter.
Entités concernées
Voir les preuves
1 articles · 1 publication d'origine · 1 independantes
- U.S. Department of JusticeSource primaire · Confirme · EN · 100%Delaware Company to Pay More Than $3.34 Million to Resolve False Claims Act Allegations Related to Paycheck Protection Program Loan ↗
Affirmations
- Delaware Company to Pay More Than $3.34 Million to Resolve False Claims Act Allegations Related to Paycheck Protection Program Loan Observé
Divergences
Aucune divergence importante détectée dans les preuves disponibles.
Chronologie
- Premier signalement
Mouvement de marché suivant l'événement
La réaction du marché n'est pas encore disponible pour cet actif et cette fenêtre.